<DOC>
	<DOC>NCT00909688</DOC>
	<brief_summary>To determine the safety, tolerability, and drug absorption profile of multiple IV doses of BLI 489 in healthy subjects.</brief_summary>
	<brief_title>Study to Evaluate Whether BLI-489 Can be Safely Tolerated by Healthy Subjects Given Multiple Doses</brief_title>
	<detailed_description />
	<mesh_term>BLI-489</mesh_term>
	<criteria>Men or women of nonchildbearing potential (WONCBP) aged 18 to 50 years inclusive at screening; Body mass index (BMI) in the range of 18 to 32 kg/m2 and body weight â‰¥50 kg.; Healthy as determined by the investigator on the basis of screening evaluations; Calculated creatinine clearance within normal limits using the CockcroftGault formula; Nonsmoker or smoker of fewer than 10 cigarettes per day as determined by history, and if a smoker must be able to abstain from smoking during the inpatient stay; Have a high probability for compliance with and completion of the study. Presence or history of any disorder that may prevent the successful completion of the study; Any significant cardiovascular, hepatic, renal, respiratory, gastrointestinal, endocrine, immunologic, dermatologic, hematologic, neurologic, or psychiatric disease; Any surgical or medical condition that may interfere with the distribution, metabolism, or excretion of the investigational product; Acute disease state (eg, nausea, vomiting, fever, or diarrhea) within 7 days before study day 1; History of drug abuse within 1 year before study day 1; Admitted alcohol abuse or history of alcohol use that may interfere with the subject's ability to comply with the protocol requirements.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Healthy Subjects</keyword>
</DOC>